Nozzles for nasal drug delivery
A nozzle for use in delivering a mixture of aerosol propellant and drug formulation. The nozzle includes a drug product inlet configured to receive a mixture of aerosolized propellant and an intranasal dosage form. The inlet is disposed at the proximal end. A nozzle body is secured to the drug product inlet. Two or more channels are disposed within the body. Two or more orifice apertures are disposed at the distal end of the nozzle.
1. A nozzle for delivering an intranasal dosage form, the nozzle comprising:
a drug product inlet configured to receive a mixture of an aerosolized propellant and the intranasal dosage form, the drug product inlet disposed at a proximal end of the nozzle and configured to be in fluid communication with a container containing propellant,
a nozzle body defining a plurality of channels, each of the plurality of channels having a proximal end and a distal end, the nozzle body defining a longitudinal axis, wherein the channels are disposed parallel to the longitudinal axis and are symmetric about a circle around the longitudinal axis, and wherein the proximal end of each of the plurality of channels is configured to be in fluid communication with the drug product inlet such that the received mixture passes through each of the channels, and
an outlet orifice disposed at the distal end of each channel defined by the nozzle body such that the outlet orifices generate a plurality of streams of the mixture that form a plume once exited the outlet orifices, wherein an angle of the plume does not exceed 5 degrees.
2. The nozzle of claim 1 , wherein the plume has a deposition width of 2.87 millimeters or less at a distance of 4 centimeters relative to the outlet orifices.
3. The nozzle of claim 1 , wherein the plume has a deposition width of 2.18 millimeters or less at a distance of 4 centimeters relative to the outlet orifices.
4. The nozzle of claim 1 , wherein the plume has a deposition width of 1.95 millimeters or less at a distance of 4 centimeters relative to the outlet orifices.
5. The nozzle of claim 1 , wherein the plume has a deposition width of 1.36 millimeters or less at a distance of 4 centimeters relative to the outlet orifices.
6. The nozzle of claim 1 , wherein the plume has a deposition width between 1.36 millimeters and 2.87 millimeters at a distance of 4 centimeters relative to the outlet orifices.
7. The nozzle of claim 1 , wherein the nozzle comprises between four to eleven channels.
8. The nozzle of claim 1 , wherein a length of each channel is between approximately 5 millimeters and approximately 21 millimeters.
9. The nozzle of claim 1 , wherein each of the outlet orifices is circular.
10. The nozzle of claim 1 , wherein the nozzle is configured to couple to a container containing the intranasal dosage form.
11. The nozzle of claim 1 , wherein the nozzle and a container containing the intranasal dosage form are of uniform construction.
12. A nozzle for delivering an intranasal dosage form, the nozzle comprising:
a container containing the intranasal dosage form;
a drug product inlet configured to receive a mixture of an aerosolized propellant and the intranasal dosage form, the drug product inlet disposed at a first end of the nozzle,
a nozzle body defining a plurality of channels and a longitudinal axis, wherein the channels are disposed parallel to the longitudinal axis and are symmetric about a circle around the longitudinal axis,
an outlet orifice disposed at a distal end of each channel, the aerosolized propellent configured to propel the intranasal dosage form from the drug product inlet through the plurality of channels and out the outlet orifices such that the outlets generate a plurality of streams that form a plume once exited the outlet orifices, wherein an angle of the plume does not exceed 5 degrees.
13. The nozzle of claim 12 , wherein the nozzle comprises between four to eleven channels.
14. The nozzle of claim 12 , wherein a length of each channel is between approximately 5 millimeters and approximately 21 millimeters.
15. The nozzle of claim 12 , wherein each of the outlet orifices is circular.
16. The nozzle of claim 12 , wherein the nozzle is configured to couple to the container containing the intranasal dosage form.
17. The nozzle of claim 12 , wherein the nozzle and the container containing the intranasal dosage form are of uniform construction.